Delivery Order SPE2DB20D1004-SPE2DB23FG2D1

Award Date 7/12/23
Potential Completion Date 7/13/23
Potential Value $1.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of JANUMET XR 50-1,000 MG TABLET 60S. The contract has a ceiling value of $17,410.79 and a period of performance through March 24, 2022. This is a firm fixed-price delivery order contract. The award is not designated with a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This federal contract award, valued at $36,954.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product, and has an ultimate completion date of June 6, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,607.94, is a delivery order for JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract has an ultimate completion date of November 30, 2023 and is a firm fixed-price delivery order. The award was not designated with a set-aside...
This federal contract award, valued at $1,437.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of JANUMET XR 100-1,000 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 21, 2025 and is a firm fixed-price delivery order. The contract is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Janumet XR 100-1,000 mg tablets. The contract has a ceiling value of $1,386.78 and a period of performance through May 7, 2024. It is a firm-fixed price delivery order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. This contract...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of the pharmaceutical product JANUMET XR 50-1,000 MG TABLET 180S, with a ceiling value of $7,408.52 and a completion date of May 11, 2023. The contract is a firm fixed-price delivery order that was awarded on May 10, 2023, with no set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Delivery Order, valued at $1,391.43, is for the pharmaceutical product Janumet XR 50-1,000 mg Tablet 60s. The contract has a Firm Fixed Price pricing type and an ultimate completion date of January 30, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,137.62 firm fixed-price delivery order is for the supply of JANUMET XR 50-500 MG TABLET 180S, a pharmaceutical product. The contract has an ultimate completion date of January 16, 2025 and was awarded on January 15, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,252.72, is for the delivery of JANUMET XR 50-1,000 MG TABLET 60S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 17, 2023. The contract is not associated with a set-aside designation....
This federal contract award is a delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $6,945.50, is for the supply of JANUMET XR 50-1,000 MG tablets. The contract has an ultimate completion date of August 5, 2024 and is a firm fixed-price delivery order. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FG2D1
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order for pharmaceutical products, specifically the drug JANUMET XR 50-1,000 MG TABLET 180S. The contract has a ceiling value of $1,744.61 and an ultimate completion date of July 13, 2023. The contract was awarded on July 12, 2023 and is a Firm Fixed Price contract type. This award is not associated with a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor, has an extensive Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026, which serves as a primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 10:50 AM